Log in to save to my catalogue

Uncovering naringin’s anticancer mechanisms in glioblastoma via molecular docking and network pharma...

Uncovering naringin’s anticancer mechanisms in glioblastoma via molecular docking and network pharma...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e557675af154fff819802f0ab0503e5

Uncovering naringin’s anticancer mechanisms in glioblastoma via molecular docking and network pharmacology approaches

About this item

Full title

Uncovering naringin’s anticancer mechanisms in glioblastoma via molecular docking and network pharmacology approaches

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-09, Vol.14 (1), p.21486-17, Article 21486

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Naringin, a flavonoid, exhibits diverse therapeutic properties and has been proven to exert cytotoxic effects on cancer cells. Nevertheless, the precise mechanism of naringin maintaining its cytotoxic effect on glioblastoma (GBM) remains unknown. Thus, the current study aimed to establish a plausible cellular mechanism for Naringin’s inhibition of...

Alternative Titles

Full title

Uncovering naringin’s anticancer mechanisms in glioblastoma via molecular docking and network pharmacology approaches

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9e557675af154fff819802f0ab0503e5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e557675af154fff819802f0ab0503e5

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-72475-z

How to access this item